Related Experiment Video
Updated: Jul 14, 2026
11:27
X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Oligopeptidase B from L. amazonensis: molecular cloning, gene expression analysis and molecular model
Herbert Leonel de Matos Guedes1, Monique Pacheco Duarte Carneiro, Daniel Cláudio de Oliveira Gomes
1Laboratório de Bioquímica de Proteínas e Peptídeos, Departamento de Bioquímica e Biologia Molecular, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
Parasitology Research
|May 29, 2007
Summary
Oligopeptidase B from Leishmania amazonensis (La_OpB) is a potential drug target for treating trypanosome infections. Its unique structural features suggest it could be a valuable target for developing new chemotherapies.
Area of Science:
- Parasitology
- Molecular Biology
- Structural Biology
Background:
- Serine oligopeptidases in trypanosomatids are key virulence factors.
- These enzymes are crucial targets for antiparasitic drug development.
Purpose of the Study:
- To characterize oligopeptidase B from Leishmania amazonensis (La_OpB).
- To explore La_OpB as a potential therapeutic target for leishmaniasis.
Main Methods:
- Polymerase chain reaction (PCR) amplification of the La_OpB gene.
- Homology modeling to determine the three-dimensional structure of La_OpB.
- Sequence identity analysis and comparison with related enzymes.
Main Results:
- The La_OpB gene codes for a 731-amino acid protein (83.49 KDa).
- La_OpB shows high sequence identity (90%) with homologous enzymes from other Leishmania species.
- Structural analysis revealed distinct features, including a more negative charge and differences in the S2 subsite compared to bacterial and Trypanosoma oligopeptidases B.
- The gene is expressed across all developmental stages of L. amazonensis.
Conclusions:
- La_OpB is a promising drug target due to its role in virulence and unique structural characteristics.
- The 3D model of La_OpB provides a basis for rational drug design against trypanosome infections.
